S.C. Heslinga
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
-
- Psoriasis: Treatment and Pathogenesis
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Spondyloarthritis Studies and Treatments 4
- Rheumatoid Arthritis Research and Therapies 3
- Systemic Lupus Erythematosus Research 2
-
- Hepatitis C virus research 1
- Co-authors
- Michael Twahier Nurmohamed (4 shared papers)Vokko P. van Halm (3 shared papers)Alper M. van Sijl (1 shared paper)Katalin Boér (1 shared paper)Irene E. van der Horst-Bruinsma (2 shared papers)Timo K. van den Berg (1 shared paper)Otto Kamp (1 shared paper)Judy Geissler (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (2 papers)Arthritis & Rheumatology (1 paper)Heart (1 paper)Current Medicinal Chemistry (1 paper)Rheumatology International (1 paper)
- Partner nations
- NetherlandsSwedenUnited Kingdom
In The Last Decade
S.C. Heslinga
6 papers receiving 1.1k citations
S.C. Heslinga's Hit Papers
Peers
Comparison fields: 5 of 66
- Rheumatology 767
- Immunology 184
- Hematology 86
- Cardiology and Cardiovascular Medicine 143
- Hepatology 27
Countries citing papers authored by S.C. Heslinga
This map shows the geographic impact of S.C. Heslinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.C. Heslinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.C. Heslinga more than expected).
Fields of papers citing papers by S.C. Heslinga
This network shows the impact of papers produced by S.C. Heslinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.C. Heslinga. The network helps show where S.C. Heslinga may publish in the future.
Co-authors
The 22 scholars most cited alongside S.C. Heslinga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update Hit paper breakdown → | 2016 | 997 |
| 2 | 2016 | 85 | |
| 3 | 2015 | 13 | |
| 4 | 2021 | 11 | |
| 5 | 2015 | 10 | |
| 6 | 2019 | 4 |
About S.C. Heslinga
S.C. Heslinga is a scholar working on Rheumatology, Hepatology, Hematology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 1.1k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Systemic Lupus Erythematosus Research (2 papers), Hepatitis C virus research (1 paper), Viral Infections and Immunology Research (1 paper), Autoimmune and Inflammatory Disorders Research (1 paper) and Vasculitis and related conditions (1 paper). The work is most often cited by research in Rheumatology (767 citations), Immunology (184 citations), Hematology (86 citations), Cardiology and Cardiovascular Medicine (143 citations) and Hepatology (27 citations). S.C. Heslinga has collaborated with scholars based in Netherlands, Sweden and United Kingdom. Frequent co-authors include Michael Twahier Nurmohamed, Vokko P. van Halm, Alper M. van Sijl, Katalin Boér, Irene E. van der Horst-Bruinsma, Timo K. van den Berg, Otto Kamp, Judy Geissler, J. Bart A. Crusius and Thelma C. Konings. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Heart, Current Medicinal Chemistry and Rheumatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.